Modifications Made for Minimally Invasive Gynecologic Oncology Surgery During the COVID-19 Pandemic Period

Area of Science:

• Oncology
• Infectious Disease Control
• Surgical Innovation

Background:

• The COVID-19 pandemic presented significant challenges to healthcare, particularly in surgical settings.
• Minimally invasive surgery (MIS) raised concerns regarding aerosol generation and potential viral transmission.
• Gynecologic oncology units faced the need to adapt surgical practices to mitigate these risks.

Purpose of the Study:

• To outline protective strategies for performing MIS in a gynecologic oncology unit during the COVID-19 pandemic.
• To detail measures aimed at minimizing aerosolized viral particle spread during surgical procedures.
• To ensure the safety of patients and healthcare professionals in a high-risk environment.

Main Methods:

• Implementation of enhanced protective measures during anesthesia induction and maintenance.
• Specific protocols for safe trocar insertion to minimize aerosol release.
• Adoption of surgical techniques and precautions to reduce viral particle dissemination.
• Utilization of specialized smoke evacuation systems equipped with viral filters.

Main Results:

• The implemented measures effectively addressed concerns regarding aerosolization during MIS.
• A comprehensive approach to infection control was established for gynecologic oncology procedures.
• The study highlights successful adaptation of surgical practices to pandemic conditions.

Conclusions:

• Minimally invasive surgery can be performed safely during the COVID-19 pandemic with appropriate precautions.
• Strict adherence to protective protocols, including specialized smoke management, is crucial.
• These strategies are vital for maintaining oncologic surgical care while controlling viral transmission.